Page 3 - Fritz Hoffmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Roche's 125th year anniversary: a history of sustainable innovation

The head of Roche's controlling group of shareholders is very confident stability can be maintained at the pharmaceuticals company after the next generation of heirs joined the family pool of... | October 17, 2021

Long ago Roche bet on personalised health care. Now its time has come | Business

Markets In a report issued on April 21, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on Roche Holding AG (RHHVF – Research Report), with a price target of CHF325.00. The company’s shares closed last Friday at $336.00. According to TipRanks.com, Papadakis is a 2-star analyst with an average return of 1.0% and a 55.2% success rate. Papadakis covers the Healthcare sector, focusing on stocks such as GlaxoSmithKline, Galapagos, and Sanofi. The word on The Street in general, suggests a Hold analyst consensus rating for Roche Holding AG with a $373.72 average price target, rep...

Markets In a report released today, Elmar Kraus from DZ BANK AG maintained a Hold rating on Roche Holding AG (RHHVF – Research Report). The company’s shares closed last Friday at $340.50. According to TipRanks.com, Kraus is a 3-star analyst with an average return of 11.1% and a 66.7% success rate. Kraus covers the Healthcare sector, focusing on stocks such as Siemens Healthineers AG, Pfizer, and Biogen. The word on The Street in general, suggests a Hold analyst consensus rating for Roche Holding AG with a $373.07 average price target, implying a 10.2% upside from current levels. In a rep...